Further studies of in vitro and in vivo models of ovarian cancer have shown that non-canonical NF-κB signaling promotes cell growth and tumorigenicity as well as cancer stem cell self-renewal [31, 32, 34, 35]. This evidence concerns the gene NFKB1 and ovarian cancer.